Amanote Research

Amanote Research

    RegisterSign In

The Clinical Promise of Immunotherapy in Triple-Negative Breast Cancer

Cancer Management and Research - New Zealand
doi 10.2147/cmar.s185176
Full Text
Open PDF
Abstract

Available in full text

Categories
Oncology
Date

December 1, 2018

Authors
Praveen VikasNicholas BorcherdingWeizhou Zhang
Publisher

Informa UK Limited


Related search

Role of Immunotherapy in Triple-Negative Breast Cancer

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2020English

Mesothelin, a Novel Immunotherapy Target for Triple Negative Breast Cancer

Breast Cancer Research and Treatment
Cancer ResearchOncology
2012English

Triple-Negative Breast Cancer

2018English

Incidence and Clinical Profile of Triple Negative Breast Cancer in Kashmir

Journal of Medical Science And clinical Research
2017English

Triple Negative Breast Cancer: Breast Cancer Research in Evolution

Breast Disease
MedicineCancer ResearchOncology
2011English

MicroRNAs Expression in Triple Negative vs Non Triple Negative Breast Cancer in Tunisia: Interaction With Clinical Outcome

PLoS ONE
Multidisciplinary
2014English

FZD7 in Triple Negative Breast Cancer Cells

2011English

Triple Negative Breast Cancer: Heterogenous Disease

REVIEWS IN ONCOLOGY
2013English

A Review of Triple-Negative Breast Cancer

Cancer Control
MedicineOncologyHematology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy